Article ; Online: The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes.
2021 Volume 42, Page(s) 101958
Abstract: The soluble receptor for advanced glycation end-products (sRAGE) has been classically considered a sink for pro-inflammatory RAGE ligands and as such has been associated with protection from inflammatory stress and disease. An alternative, though not ... ...
Abstract | The soluble receptor for advanced glycation end-products (sRAGE) has been classically considered a sink for pro-inflammatory RAGE ligands and as such has been associated with protection from inflammatory stress and disease. An alternative, though not mutually exclusive view is that high levels of sRAGE in circulation reflect the overstimulation of cell surface RAGE which if persistent, lead to the amplification of pro-inflammatory processes and the exacerbation of pathological states. With these two scenarios in mind this review focuses on the potential role of sRAGE as a prospective biomarker of disease risk and adverse outcomes. |
---|---|
MeSH term(s) | Biomarkers ; Disease ; Glycation End Products, Advanced ; Humans ; Prospective Studies ; Receptor for Advanced Glycation End Products |
Chemical Substances | Biomarkers ; Glycation End Products, Advanced ; Receptor for Advanced Glycation End Products |
Language | English |
Publishing date | 2021-03-29 |
Publishing country | Netherlands |
Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Review |
ZDB-ID | 2701011-9 |
ISSN | 2213-2317 ; 2213-2317 |
ISSN (online) | 2213-2317 |
ISSN | 2213-2317 |
DOI | 10.1016/j.redox.2021.101958 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.